• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用预测性检测板评估氨苄西林-舒巴坦的药敏试验方法。

Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.

作者信息

Bradford P A, Sanders C C

机构信息

Department of Medical Microbiology, Creighton University, Omaha, Nebraska 68178-0213.

出版信息

Antimicrob Agents Chemother. 1993 Feb;37(2):251-9. doi: 10.1128/AAC.37.2.251.

DOI:10.1128/AAC.37.2.251
PMID:8452355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC187648/
Abstract

A predictor panel of clinical isolates that produce a variety of types and amounts of beta-lactamases was used to assess the accuracies of a variety of susceptibility tests for ampicillin-sulbactam. Combinations of ampicillin-sulbactam in ratios of 1:1 and 2:1 and with sulbactam held constant at concentrations of 4 and 8 micrograms/ml were examined in dilution tests performed in agar and broth. In addition, disks containing 10/10, 20/10, 20/20, and 20/30 micrograms of ampicillin-sulbactam were examined in diffusion tests. The results indicated that the MICs obtained in broth microdilution tests performed with each of the four combinations differed, on average, less than twofold. Of the disks tested, the 20/10-micrograms ampicillin-sulbactam disk provided the best separation between susceptible and resistant strains when interpretive criteria for resistance was a zone size of < or = 16 mm and that for susceptibility was a zone size of > or = 21 mm. This disk also gave the highest overall agreement with MICs, regardless of the combination used in the broth microdilution test. Discrepancies between agar and broth microdilution MICs were greater than twofold, on average, and this necessitated recommendation of separate criteria for the two methods. Thus, a predictor panel was very useful in identifying the parameters of susceptibility tests that were most accurate in identifying strains that were susceptible and resistant to ampicillin-sulbactam.

摘要

使用一组能产生多种类型和数量β-内酰胺酶的临床分离株来评估多种氨苄西林-舒巴坦药敏试验的准确性。在琼脂和肉汤中进行的稀释试验中,检测了比例为1:1和2:1且舒巴坦浓度分别保持在4微克/毫升和8微克/毫升的氨苄西林-舒巴坦组合。此外,在扩散试验中检测了含有10/10、20/10、20/20和20/30微克氨苄西林-舒巴坦的药敏纸片。结果表明,用这四种组合中的每一种进行肉汤微量稀释试验所获得的最低抑菌浓度(MIC)平均差异不到两倍。在所测试的药敏纸片中,当耐药的判断标准为抑菌圈直径≤16毫米且敏感的判断标准为抑菌圈直径≥21毫米时,20/10微克的氨苄西林-舒巴坦药敏纸片在区分敏感菌株和耐药菌株方面表现最佳。无论肉汤微量稀释试验中使用哪种组合,该药敏纸片与MIC的总体一致性也最高。琼脂稀释法和肉汤微量稀释法的MIC之间的差异平均大于两倍,因此有必要针对这两种方法推荐不同的标准。因此,一组预测性分离株对于确定在识别对氨苄西林-舒巴坦敏感和耐药菌株方面最准确的药敏试验参数非常有用。

相似文献

1
Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.使用预测性检测板评估氨苄西林-舒巴坦的药敏试验方法。
Antimicrob Agents Chemother. 1993 Feb;37(2):251-9. doi: 10.1128/AAC.37.2.251.
2
Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.使用预测性检测板开发用于头孢哌酮-舒巴坦扩散试验的新型试纸条。
Antimicrob Agents Chemother. 1992 Feb;36(2):394-400. doi: 10.1128/AAC.36.2.394.
3
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical response.应用于氨苄西林/舒巴坦抗菌药物敏感性试验的微生物学和药效学原理:体外试验结果与临床反应之间的相关性分析
Diagn Microbiol Infect Dis. 1997 May;28(1):5-18. doi: 10.1016/s0732-8893(97)00013-8.
4
Proposed changes in interpretive criteria and potency of ampicillin and ampicillin-sulbactam disks for susceptibility tests.关于氨苄西林及氨苄西林-舒巴坦药敏试验纸片的解释标准和效力的拟议变更。
J Clin Microbiol. 1988 Apr;26(4):750-4. doi: 10.1128/jcm.26.4.750-754.1988.
5
Broth-disk elution tests to predict the susceptibility of anaerobic bacteria to the ampicillin-sulbactam combination.肉汤纸片洗脱试验预测厌氧菌对氨苄西林-舒巴坦联合制剂的敏感性。
Diagn Microbiol Infect Dis. 1990 Jul-Aug;13(4):353-5. doi: 10.1016/0732-8893(90)90031-p.
6
Ampicillin-sulbactam susceptibility testing criteria.氨苄西林-舒巴坦药敏试验标准。
Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):469-72. doi: 10.1007/BF01967446.
7
Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.氨苄西林-舒巴坦组合的最佳稀释药敏试验条件、MIC解释建议及质量控制指南。
J Clin Microbiol. 1987 Oct;25(10):1920-5. doi: 10.1128/jcm.25.10.1920-1925.1987.
8
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.革兰氏阴性杆菌对氨苄西林和氨苄西林/舒巴坦稀释药敏试验的固定浓度和固定比例选项比较。
Eur J Clin Microbiol Infect Dis. 1993 May;12(5):356-62. doi: 10.1007/BF01964434.
9
Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam.流感嗜血杆菌临床分离株对氨苄西林-舒巴坦的抗菌药敏性
Diagn Microbiol Infect Dis. 1990 Jul-Aug;13(4):341-4. doi: 10.1016/0732-8893(90)90028-t.
10
Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid.厌氧菌对氨苄西林-舒巴坦和阿莫西林-克拉维酸敏感性体外检测方法的评估。
J Clin Microbiol. 1988 Jun;26(6):1246-7. doi: 10.1128/jcm.26.6.1246-1247.1988.

引用本文的文献

1
Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests.舒巴坦-他唑巴坦药敏试验方法的建立及 MIC 和纸片扩散试验的质量控制范围。
J Clin Microbiol. 2024 Jan 17;62(1):e0122823. doi: 10.1128/jcm.01228-23. Epub 2023 Dec 14.
2
A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing.一种系统的方法,用于选择合适的阿维巴坦浓度与头孢他啶联合用于肉汤微量稀释法药敏试验。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00223-18. Print 2018 Jul.
3
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.哌拉西林与青霉烯类β-内酰胺酶抑制剂BLI-489联合应用的体外药敏试验方法的建立及比较活性
Antimicrob Agents Chemother. 2009 Feb;53(2):370-84. doi: 10.1128/AAC.01047-08. Epub 2008 Nov 10.
4
Pharmacodynamics of ampicillin-sulbactam in an in vitro infection model against Escherichia coli strains with various levels of resistance.氨苄西林-舒巴坦在针对不同耐药水平大肠杆菌菌株的体外感染模型中的药效学
Antimicrob Agents Chemother. 1998 Feb;42(2):231-5. doi: 10.1128/AAC.42.2.231.
5
Response of enteric gram-negative bacteria to disks containing 20 micrograms each of ampicillin and sulbactam.肠道革兰氏阴性菌对每片含20微克氨苄西林和舒巴坦的药敏纸片的反应。
J Clin Microbiol. 1997 Feb;35(2):523-4. doi: 10.1128/jcm.35.2.523-524.1997.
6
Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactions.氨苄西林-舒巴坦的疗效并不取决于各组分之间维持关键比例:药效学相互作用中的舒巴坦药代动力学。
Antimicrob Agents Chemother. 1996 Nov;40(11):2468-77. doi: 10.1128/AAC.40.11.2468.
7
Use of a predictor panel to evaluate susceptibility test methods proposed for piperacillin-tazobactam.使用预测指标组评估针对哌拉西林-他唑巴坦提出的药敏试验方法。
Antimicrob Agents Chemother. 1993 Dec;37(12):2578-83. doi: 10.1128/AAC.37.12.2578.

本文引用的文献

1
Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks.氨苄西林-舒巴坦复合纸片药敏试验的解释标准和质量控制限度
J Clin Microbiol. 1984 Feb;19(2):134-9. doi: 10.1128/jcm.19.2.134-139.1984.
2
Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.厌氧菌药敏试验:统计学与临床考量
J Infect Dis. 1974 Dec;130(6):588-94. doi: 10.1093/infdis/130.6.588.
3
Characterization of beta-lactamases in situ on polyacrylamide gels.聚丙烯酰胺凝胶上β-内酰胺酶的原位表征
Antimicrob Agents Chemother. 1986 Dec;30(6):951-2. doi: 10.1128/AAC.30.6.951.
4
Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.革兰氏阴性菌的I型β-内酰胺酶:与β-内酰胺类抗生素的相互作用
J Infect Dis. 1986 Nov;154(5):792-800. doi: 10.1093/infdis/154.5.792.
5
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.肠杆菌科临床分离株对替卡西林-克拉维酸钾的耐药性:PSE-1β-内酰胺酶、高水平TEM-1和SHV-1的作用以及纸片扩散法检测中假敏感问题
Antimicrob Agents Chemother. 1988 Sep;32(9):1365-9. doi: 10.1128/AAC.32.9.1365.
6
Proposed changes in interpretive criteria and potency of ampicillin and ampicillin-sulbactam disks for susceptibility tests.关于氨苄西林及氨苄西林-舒巴坦药敏试验纸片的解释标准和效力的拟议变更。
J Clin Microbiol. 1988 Apr;26(4):750-4. doi: 10.1128/jcm.26.4.750-754.1988.
7
Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.氨苄西林-舒巴坦组合的最佳稀释药敏试验条件、MIC解释建议及质量控制指南。
J Clin Microbiol. 1987 Oct;25(10):1920-5. doi: 10.1128/jcm.25.10.1920-1925.1987.
8
Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Drugs. 1987 Jun;33(6):577-609. doi: 10.2165/00003495-198733060-00003.
9
Penetration of ampicillin and sulbactam in the lower airways during respiratory infections.呼吸道感染期间氨苄西林和舒巴坦在下呼吸道的穿透情况。
Antimicrob Agents Chemother. 1990 Jun;34(6):958-62. doi: 10.1128/AAC.34.6.958.
10
In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.氨苄西林-舒巴坦和头孢哌酮-舒巴坦对苯唑西林敏感和耐药葡萄球菌的体外活性
Antimicrob Agents Chemother. 1990 Sep;34(9):1830-2. doi: 10.1128/AAC.34.9.1830.